Long-term use of melatonin supplements, often used to promote sleep and address insomnia, is associated with a higher risk of heart failure diagnosis, heart failure, hospitalization and death from any cause in chronic insomnia, according to a preliminary study presented at the American Heart Association’s Scientific Sessions 2025, held Nov. 7–10, in New Orleans.
This article was originally published on MedicalXpress.com

